Clinical trial
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the…
NCT00433667 · SK Life Science, Inc., Industry · Completed
Key facts
| NCT number | NCT00433667 |
|---|---|
| Title | A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. |
| Official title | Epilepsy Phase III Trial |
| Lead sponsor | SK Life Science, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Focal, Seizure Disorder, Complex Partial Seizures, Complex Partial |
| Intervention type | Drug |
| Interventions | RWJ-333369 |
| Enrollment | 563 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Feb 12, 2007 |
| Last update posted | Jun 18, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: